Cell Medica: Lead Cancer Immunotherapy Candidate Receives FDA Fast Track Designation – Business Wire (press release)
|
Cell Medica: Lead Cancer Immunotherapy Candidate Receives FDA Fast Track Designation
Business Wire (press release) LONDON & HOUSTON–(BUSINESS WIRE)–Cell Medica, a leader in developing cellular immunotherapy for the treatment of cancer, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead oncology … |
